University of Ulsan / 울산대학교

Fine tuning of the magnetic properties in Mn3-xCoxGa Heusler films near the critical regime (2021) Lee K, Yoo W, Nguyen QAT, Bang HW, Kim H, Klaeui M, Rhim SH, Jung MH Journal article Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women (2021) Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, et al. Journal article Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial (2021) Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, et al. Conference contribution Study protocol for an International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon Cancer (T-REX study) (2021) Shiozawa M, Ueno H, Shiomi A, Kim NK, Kim JC, Tsarkov P, Grützmann R, et al. Journal article Effects on Photovoltaic Characteristics by Organic Bilayer- And Bulk-Heterojunctions: Energy Losses, Carrier Recombination and Generation (2020) Lee TH, Park SY, Du X, Park S, Zhang K, Li N, Cho S, et al. Journal article Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study (2019) Hurvitz SA, Martin M, Jung KH, Huang CS, Harbeck N, Valero V, Stroyakovskiy D, et al. Journal article Impact of Lesion Load Thresholds on Alberta Stroke Program Early Computed Tomographic Score in Diffusion-Weighted Imaging (2018) Schroeder J, Cheng B, Malherbe C, Ebinger M, Köhrmann M, Wu O, Kang DW, et al. Journal article Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial (2018) Hurvitz SA, Martin M, Symmans WF, Jung KH, Huang CS, Thompson AM, Harbeck N, et al. Journal article Securing safe and informative thoracic CT examinations-Progress of radiation dose reduction techniques (2017) Kubo T, Ohno Y, Seo JB, Yamashiro T, Kalender WA, Lee CH, Lynch DA, et al. Journal article